These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29788550)

  • 1. Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization.
    Qiu GZ; Mao XY; Ma Y; Gao XC; Wang Z; Jin MZ; Sun W; Zou YX; Lin J; Fu HL; Jin WL
    Cancer Sci; 2018 Jul; 109(7):2199-2210. PubMed ID: 29788550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
    Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
    Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1α.
    Qiu GZ; Liu Q; Wang XG; Xu GZ; Zhao T; Lou MQ
    Life Sci; 2020 Apr; 247():117438. PubMed ID: 32070708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis.
    Tsai YT; Wu CC; Ko CY; Hsu TI; Chang WC; Lo WL; Chuang JY
    Biochem Biophys Res Commun; 2021 Apr; 550():113-119. PubMed ID: 33691197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.
    Liang J; Zhang X; Xie S; Zhou X; Shi Q; Hu J; Wang W; Qi W; Yu R
    Med Oncol; 2014 Apr; 31(4):899. PubMed ID: 24573640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ring finger 220 promotes the stemness and progression of colon cancer cells via Ubiquitin specific peptidase 22-BMI1 axis.
    Yan J; Tan M; Yu L; Jin X; Li Y
    Bioengineered; 2021 Dec; 12(2):12060-12069. PubMed ID: 34753387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
    Oliva CR; Markert T; Gillespie GY; Griguer CE
    Oncotarget; 2015 Feb; 6(6):4330-44. PubMed ID: 25726526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-194 represses glioma cell epithelial‑to‑mesenchymal transition by targeting Bmi1.
    Zhang X; Wei C; Li J; Liu J; Qu J
    Oncol Rep; 2017 Mar; 37(3):1593-1600. PubMed ID: 28098896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
    Baxter PA; Lin Q; Mao H; Kogiso M; Zhao X; Liu Z; Huang Y; Voicu H; Gurusiddappa S; Su JM; Adesina AM; Perlaky L; Dauser RC; Leung HC; Muraszko KM; Heth JA; Fan X; Lau CC; Man TK; Chintagumpala M; Li XN
    Acta Neuropathol Commun; 2014 Dec; 2():160. PubMed ID: 25526772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.
    Chen SJ; Chen YT; Zeng LJ; Zhang QB; Lian GD; Li JJ; Yang KG; Huang CM; Li YQ; Chu ZH; Huang KH
    Tumour Biol; 2016 Aug; 37(8):11299-309. PubMed ID: 26951514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth.
    Xu H; Liu YL; Yang YM; Dong XS
    Int J Colorectal Dis; 2012 Jan; 27(1):21-30. PubMed ID: 21773699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.
    Okamoto T; Yamazaki H; Hatano R; Yamada T; Kaneko Y; Xu CW; Dang NH; Ohnuma K; Morimoto C
    Biochem Biophys Res Commun; 2018 Oct; 504(2):491-498. PubMed ID: 30197002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cells.
    Liang J; Zhang XL; Li S; Xie S; Wang WF; Yu RT
    Cancer Biomark; 2018; 23(3):381-389. PubMed ID: 30223389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
    Li J; Gao R; Zhang J
    Clin Breast Cancer; 2023 Feb; 23(2):162-175. PubMed ID: 36528490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deubiquitinating enzyme activity of USP22 is necessary for regulating HeLa cell growth.
    Liu YL; Zheng J; Tang LJ; Han W; Wang JM; Liu DW; Tian QB
    Gene; 2015 Nov; 572(1):49-56. PubMed ID: 26143114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.
    Schrecengost RS; Dean JL; Goodwin JF; Schiewer MJ; Urban MW; Stanek TJ; Sussman RT; Hicks JL; Birbe RC; Draganova-Tacheva RA; Visakorpi T; DeMarzo AM; McMahon SB; Knudsen KE
    Cancer Res; 2014 Jan; 74(1):272-86. PubMed ID: 24197134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells.
    Kim D; Hong A; Park HI; Shin WH; Yoo L; Jeon SJ; Chung KC
    J Cell Physiol; 2017 Dec; 232(12):3664-3676. PubMed ID: 28160502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.